Tourbillon Capital Partners, L.P. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 3 filers reported holding CRISPR THERAPEUTICS AG in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tourbillon Capital Partners, L.P. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q1 2018$1,600,00035,0000.06%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2018
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 310$2,279,0000.16%
GROUP ONE TRADING, L.P. 23,600$1,734,0000.01%
SIMPLEX TRADING, LLC 489$3,593,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders